Measuring Symptom Relief After Radiofrequency Ablation of the Thyroid
Part of paid clinical trials in Rochester, Minnesota.
- Sponsor
- Mayo Clinic
- Study ID
- NCT05501041
- Status
- Enrolling By Invitation
Conditions
- Thyroid
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The purpose of this study is to measure the impact of thyroid radiofrequency ablation procedure on patients with thyroid-related symptoms using a modified pre-existing scoring system.
Key Dates
- Start date
- Aug 22, 2022
- Status verified
- Sep 2025
- Primary completion
- Aug 31, 2026
- Completion
- Aug 31, 2028
Study Design
- Enrollment
- 300 participants (estimated)
Primary Outcome Measure
Change in symptoms before and after ablation [ Time Frame: Baseline and 1-, 3-, 6-, 12-, 18-, and 24-months following treatment ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic Rochester | Rochester | Minnesota | 55905 | - |
Find similar trials in Rochester, MN
By research site
Related Studies
- Exparel Injection Effect on Postoperative Opioid UsageEARLY_PHASE1 · Enrolling By Invitation · University of Missouri-Columbia · Columbia, Missouri
- Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint InhibitorsRecruiting · Icahn School of Medicine at Mount Sinai · New York, New York
- A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid CancerRecruiting · Memorial Sloan Kettering Cancer Center · New York, New York